Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluating Smoking Cessation Interventions for PWH in South Africa
NCT05413122Phase 3Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Nov 2023
- Primary completion
- Aug 2027
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of varenicline, nicotine patch, nicotine in Tobacco Use Disorder (TUD), sponsored by Johns Hopkins University. Started Nov 2023; status: recruiting.
02
Drugs
vareniclinenicotine patchnicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT05413122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05413122.